期刊文献+

PKCβ1、PKCβ2和P53在结肠癌、腺瘤中的表达

Expression of PKCβ1、PKCβ2 and P53 in carcinoma and adenoma of colon
下载PDF
导出
摘要 目的观察PKCβ1、PKCβ2和P53在结肠肿瘤及其相应正常腺体中的表达情况。方法回顾分析23例结肠癌、20例结肠腺瘤的临床病理资料,并对相应组织及瘤周正常结肠黏膜进行PKCβ1、PKCβ2和P53等免疫组化染色。结果PKCβ1表达在结肠癌与腺瘤和正常黏膜差异显著,表达率和表达强度依次递减;PKCβ2在三者的表达率均低且相互间差异不显著;P53主要表达于中低分化的结肠癌及伴有中重度不典型增生的腺瘤,且结肠癌中的表达显著高于结肠腺瘤,正常黏膜不表达P53。结论PKCβ1可能与结肠黏膜上皮增生有关,可能参与了结肠的癌变过程,并可能在癌变早期发生改变;P53在判断良恶性方面具有重要意义。 Objective To study the expression of PKCβ1, PKCβ2 and P53 in carcinomas and adenomas of colon. Methods The clinical and pathologic materials of 23 cases of adenocarcinoma and 20 cases of adenoma were reviewed stainings for PKCβ1, PKCβ2 and P53 were performed on paraffin sections. Results The expression of PKCβ1 in carcinoma tissues is significantly more strong than in adenoma and normal colon mucosa, and their expression rate and intensity were gradually decreased. There were no difference among carcinoma, adenoma and normal mucosa for the expression of PKCβ2. P53 was mostly expressed by moderately or poorly differentiated adenocarcinomas, and adenomas with moderate to severe dysplasia. The expression of P53 in carcinomas was significantly more strong than that in adenoma, and normal mucosa was negative for P53. Conclusion The expression of PKCβ1 may be related to the proliferation of colonic epithelium and early involved in the pathway of colonic carcinogenesis. P53 is an important index to judge benign lesions from malignant lesions.
出处 《诊断病理学杂志》 CSCD 2005年第4期296-298,i0015,共4页 Chinese Journal of Diagnostic Pathology
关键词 结肠癌 结肠腺瘤 PKCβ1 PKCβ2 P53 Colonic adenocarcinoma Colonic adenoma PKC PKCβ1 PKCβ2 P53
  • 相关文献

参考文献12

  • 1冯瑞娥,陈杰,崔全才,詹阳,王振宇.PKCβ1和PKCβ2在早期胃癌中的表达[J].世界华人消化杂志,2003,11(9):1286-1289. 被引量:4
  • 2马强,张振书,张亚历,王群英,赖卓胜.蛋白激酶C对大肠癌耐药株LoVo/Adr细胞多药耐药性的影响[J].第一军医大学学报,2002,22(7):626-628. 被引量:1
  • 3韩英,时永全,张宏博,张淼利,王春梅,樊代明.肿胀激活状态下蛋白激酶C同工酶亚型在胃癌耐药细胞系的亚细胞分布变化及其意义[J].中华医学杂志,2001,81(6):328-331. 被引量:7
  • 4Teicher BA, Menon K, Alvarez E, et al. Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human HT-29 colon carcinoma and human CaKil renal cell carcinoma xenografts[ J]. Anticancer Res,2001,21(5) :3175 - 3184.
  • 5Langzam L, Koren R, Gal R, et al. Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy[ J ]. Am J Clin Pathol, 2001,116(3 ) : 377- 385.
  • 6Clark AS, West KA, Blumberg PM, et al. Altered protein kinase C(PKC) isoforms in non-small cell lung cancer cells: PKC delta promotes cellular survival and chemotherapeutic resistunee [ J ]. Cancer,Res,2003,63(4) :780 - 786.
  • 7Sagawa N, Fujita H, Banno Y, et al. Gelsolin suppresses tmnorigenicity through inhibiting PKC activation in a human lung cancer cell line,PCIO[ J]. Br J Cancer,2003,88(4) :606 - 612.
  • 8Jarzabek K, Laudanski P, Dzieciol J, et al. Protein kinase C involvement in proliferation and survival of breast cancer cells[J]. Folia Histochem Cytobiol,2002,40(2) : 193 - 194.
  • 9Gokmen-Polar Y, Murray NR, velasco MA, et al. Elevated protein kinase C beta Ⅱ is an early prornotive event in colon carcinogenesis[J]. Cancer Res,2001,61(4) : 1375 - 1381.
  • 10Atten M.l,Attar BM, Milson T, et al. Resveratml-induced inactivation of human gastric adenocarcinoma cells through a protein kinase Cmediated mechanism [J ]. Biochem Pharmacol, 2001,62 ( 10 ) : 1423 -1432.

二级参考文献8

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部